• Save
EUPATI launch meeting - Michel Goldman IMI
Upcoming SlideShare
Loading in...5
×
 

EUPATI launch meeting - Michel Goldman IMI

on

  • 680 views

EUPATI Launch Meeting, 27 March 2012, Copenhagen: Presentation of Michel Goldman, IMI

EUPATI Launch Meeting, 27 March 2012, Copenhagen: Presentation of Michel Goldman, IMI

Statistics

Views

Total Views
680
Views on SlideShare
509
Embed Views
171

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 171

http://www.patientsacademy.eu 171

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

EUPATI launch meeting - Michel Goldman IMI EUPATI launch meeting - Michel Goldman IMI Presentation Transcript

  • The Innovative Medicines Initiative: Promoting patient involvement in drug development Michel Goldman, MD, PhD Executive Director EUPATI Launch, Copenhagen, 27 March 2012
  • Innovative Medicines Initiative:Joining public and private forces 2 Billion Euro 1 Billion € 1 Billion € Public Private Partnership
  • Core objectives • To overcome research bottlenecks in drug development through collaborative approaches • To increase investments in the biopharmaceutical sector and provide socio-economic benefits across Europe • To contribute to the health of European citizens
  • Key concepts• Non-competitive research for EFPIA companies• Competitive calls for IMI beneficiaries• Open collaboration in public-private consortia
  • Major project deliverables • Patient-reported outcomes • Predicting biomarkers • Novel approaches to drug safety • Innovative tools for translational research
  • PRO-ACTIVEPatient reported outcomes in chronicobstructive pulmonary disease Activity Monitoring PDA for PROs Physical activity Symptoms reported Time (days)
  • U-BIOPRED Towards a new taxonomy of asthmaPaves the way towards tailored treatments forasthmatic patients38 Partners - 9 EFPIA companies - 23 Academic institutions - 3 Patients’ organizations - 3 SMEsFirst achievements  A new stepwise algorithm for the stratification of patients with severe asthma Thorax, 66: 910-7 (2011)
  • Clinical Pharmacology & Therapeutics March 2012,http://www.nature.com/doifinder/10.1038/clpt.2011.321
  • Nature Medicine 18:341,2012
  • www.imi.europa.eu THANK YOU !